IL22 and type 2 diabetes mellitus: Previous clinical studies found that plasma levels of IL-22 and the number of IL-22-producing CD4+ T cells were higher in insulin-resistant or type 2 diabetic obese individuals than in insulin-sensitive obese or lean individuals [7, 8], but results were based on very small samples.